![Philip Gotwals](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Philip Gotwals
Directeur/Membre du Conseil chez
CAPRICOR THERAPEUTICS, INC.
Fortune : 89 999 $ au 31/05/2026
Profil
Philip J.
Gotwals is currently an Independent Director at Capricor Therapeutics, Inc. since 2023 and an Independent Director at OmniAb, Inc. starting in 2025.
Formerly, Dr. Gotwals was Vice President-Business Development & Licensing at Novartis Institutes for Biomedical Research, Inc. from 2019 to 2023, Vice President-Program Management at Altus Pharmaceuticals, Inc. from 2006 to 2009, and Senior Director-Early Development at Biogen, Inc. from 2004 to 2006.
Education includes undergraduate studies at Amherst College and a doctorate from the University of California, Berkeley.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
OMNIAB, INC. 0,02% | 17/06/2026 | 33 333 ( 0,02% ) | 89 999 $ | 31/05/2026 |
| 28/02/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
Postes actifs de Philip Gotwals
| Sociétés | Poste | Début |
|---|---|---|
| CAPRICOR THERAPEUTICS, INC. | Directeur/Membre du Conseil | 21/07/2023 |
| OMNIAB, INC. | Directeur/Membre du Conseil | 18/04/2025 |
Anciens postes connus de Philip Gotwals
| Sociétés | Poste | Fin |
|---|---|---|
Novartis Institutes for Biomedical Research, Inc.
 Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Conducts biomedical researches | Corporate Officer/Principal | 01/10/2023 |
Altus Pharmaceuticals, Inc.
 Altus Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops therapeutic products for gastrointestinal and metabolic diseases | Corporate Officer/Principal | 01/01/2009 |
| BIOGEN INC. | Corporate Officer/Principal | 01/09/2006 |
Redsky Partners LLC
 Redsky Partners LLC Financial ConglomeratesFinance RedSky invests long/short with a growth bias without regard to market capitalization. | Corporate Officer/Principal | - |
Formation de Philip Gotwals
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
77
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Redsky Partners LLC
Redsky Partners LLC Financial ConglomeratesFinance RedSky invests long/short with a growth bias without regard to market capitalization. | Finance |
Amherst College
 Amherst College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Berkeley
 University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Altus Pharmaceuticals, Inc.
Altus Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops therapeutic products for gastrointestinal and metabolic diseases | Health Technology |
Novartis Institutes for Biomedical Research, Inc.
Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Conducts biomedical researches | Commercial Services |
Capricor Therapeutics, Inc.
 Capricor Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops innovative products for the treatment of cardiovascular diseases | Health Technology |
OmniAb, Inc.
 OmniAb, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company | Commercial Services |
